• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼泊尔疟疾风险的微观分层:对疟疾控制与消除的启示

Micro-stratification of malaria risk in Nepal: implications for malaria control and elimination.

作者信息

Rijal Komal Raj, Adhikari Bipin, Adhikari Nabaraj, Dumre Shyam Prakash, Banjara Mayur Sharma, Shrestha Upendra Thapa, Banjara Megha Raj, Singh Nihal, Ortegea Leonard, Lal Bibek Kumar, Thakur Garib Das, Ghimire Prakash

机构信息

1Central Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal.

2Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

出版信息

Trop Med Health. 2019 Mar 27;47:21. doi: 10.1186/s41182-019-0148-7. eCollection 2019.

DOI:10.1186/s41182-019-0148-7
PMID:30976192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6437900/
Abstract

BACKGROUND

A significant reduction in malaria cases over the recent years in Nepal has encouraged the government to adopt a goal of "malaria-free nation by 2025." Nevertheless, to achieve this goal, it is critical to identify the epidemiological burden of malaria by specific regions and areas for an effective targeted intervention. The main objective of this study was to estimate the risk of malaria at Village Development Committee (VDC) level in Nepal based on disease, vector, parasite, and geography.

METHODS

In 2012, the micro-stratification of malaria risk was carried out in 75 districts of Nepal. Instruments such as a questionnaire, case record forms, and guidelines for malaria micro-stratification were developed and pre-tested for necessary adaptations. Village Development Committee (VDC)-wise malaria data were analyzed using exploratory statistics and were stratified by geographical variables that contributed to the risk of malaria. To understand the transmission risk at VDC level, overlay analysis was done using ArcGIS 10. To ensure transparent, reproducible, and comprehensible risk assessment, standard scoring method was selected and utilized for data from 2009 to 2011. Thus identified, three major variables (key determinants) were given weights (wt.) accordingly to stratification of the malaria risk (disease burden, "0.3" wt.; ecology/vector transmission, "0.5" wt.; and vulnerability-population movement, "0.2" wt.). Malaria risk in a VDC was determined based on the overall scores and classified into four categories: no risk, low risk, moderate risk, and high risk.

RESULTS

Analyzing the overall risk based on scoring of the total VDCs ( = 3976), 54 (1.36%), 201 (5.06%), 999 (25.13%), and 2718 (68.36%) were identified as high-, moderate-, low-, and no-risk categories for malaria, respectively. Based on the population statistics, 3.62%, 9.79%, 34.52%, and 52.05% of the country's total population live in high-risk, moderate-risk, low-risk, and no-risk VDCs for malaria, respectively. Our micro-stratification study estimates are 100,000 population at high risk. Regional distribution showed that the majority of the high-risk VDCs were identified in the Far- and Mid-western regions (19 and 18 VDCs) followed by Central and Western regions (10 and 7 VDCs) with no high-risk VDCs in the Eastern region. Similarly, 77, 59, 27, 24, and 14 VDCs of the Central, Mid-western, Western, Eastern, and Far-western regions, respectively, were found under moderate malaria risk. Of the low-risk VDCs, 353, 215, 191, 148, and 92 were respectively from the Central, Eastern, Western, Far-western, and Mid-western regions.

CONCLUSIONS

The current micro-stratification study provides insights on malaria risk up to the VDC level. This will help the malaria elimination program to target interventions at the local level thereby ensuring the best utilization of available resources to substantially narrowed-down target areas. With further updates and refinement, the micro-stratification approach can be employed to identify the risk areas up to smaller units within the VDCs (ward and villages).

摘要

背景

近年来尼泊尔疟疾病例显著减少,这促使政府制定了“到2025年成为无疟疾国家”的目标。然而,要实现这一目标,通过特定地区和区域确定疟疾的流行病学负担以进行有效的针对性干预至关重要。本研究的主要目的是基于疾病、病媒、寄生虫和地理因素,估计尼泊尔乡村发展委员会(VDC)层面的疟疾风险。

方法

2012年,在尼泊尔的75个区开展了疟疾风险的微观分层工作。开发了诸如问卷、病例记录表和疟疾微观分层指南等工具,并进行了预测试以作必要调整。利用探索性统计方法分析了按乡村发展委员会划分的疟疾数据,并按导致疟疾风险的地理变量进行分层。为了解乡村发展委员会层面的传播风险,使用ArcGIS 10进行了叠加分析。为确保风险评估透明、可重复且易于理解,选择并采用标准评分方法对2009年至2011年的数据进行分析。据此确定了三个主要变量(关键决定因素),并根据疟疾风险分层(疾病负担,权重“0.3”;生态/病媒传播,权重“0.5”;脆弱性 - 人口流动,权重“0.2”)相应地赋予权重。根据总分确定乡村发展委员会的疟疾风险,并分为四类:无风险、低风险、中度风险和高风险。

结果

根据对所有乡村发展委员会(共3976个)的评分分析总体风险,分别有54个(1.36%)、201个(5.06%)、999个(25.13%)和2718个(68.36%)被确定为疟疾的高风险、中度风险、低风险和无风险类别。根据人口统计数据,该国总人口的3.62%、9.79%、34.52%和52.05%分别生活在疟疾高风险、中度风险、低风险和无风险的乡村发展委员会地区。我们的微观分层研究估计有10万人口处于高风险状态。区域分布显示,大多数高风险乡村发展委员会位于远西区和中西部地区(分别为19个和18个乡村发展委员会),其次是中部和西部地区(分别为10个和7个乡村发展委员会),东部地区没有高风险乡村发展委员会。同样,中部、中西部、西部、东部和远西部地区分别有77个、59个、27个、24个和14个乡村发展委员会处于中度疟疾风险。在低风险乡村发展委员会中,分别有353个、215个、191个、148个和92个来自中部、东部、西部、远西部和中西部地区。

结论

当前的微观分层研究提供了直至乡村发展委员会层面的疟疾风险见解。这将有助于疟疾消除计划在地方层面进行针对性干预,从而确保最佳利用可用资源,大幅缩小目标区域。随着进一步更新和完善,微观分层方法可用于识别直至乡村发展委员会内更小单位(选区和村庄)的风险区域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/c654ce492ea7/41182_2019_148_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/ca0d84775edd/41182_2019_148_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/0cdfd631ac93/41182_2019_148_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/8f30b1f3bbba/41182_2019_148_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/8bdfe54f9f33/41182_2019_148_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/c802d3d2b887/41182_2019_148_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/f7f30b66aabd/41182_2019_148_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/c654ce492ea7/41182_2019_148_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/ca0d84775edd/41182_2019_148_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/0cdfd631ac93/41182_2019_148_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/8f30b1f3bbba/41182_2019_148_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/8bdfe54f9f33/41182_2019_148_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/c802d3d2b887/41182_2019_148_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/f7f30b66aabd/41182_2019_148_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c9/6437900/c654ce492ea7/41182_2019_148_Fig7_HTML.jpg

相似文献

1
Micro-stratification of malaria risk in Nepal: implications for malaria control and elimination.尼泊尔疟疾风险的微观分层:对疟疾控制与消除的启示
Trop Med Health. 2019 Mar 27;47:21. doi: 10.1186/s41182-019-0148-7. eCollection 2019.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Quantifying the potential epidemiological impact of a 2-year active case finding for tuberculosis in rural Nepal: a model-based analysis.量化尼泊尔农村地区开展为期 2 年的结核病主动病例发现的潜在流行病学影响:基于模型的分析。
BMJ Open. 2023 Nov 1;13(11):e062123. doi: 10.1136/bmjopen-2022-062123.
4
Comparison of fine-scale malaria strata derived from population survey data collected using RDTs, microscopy and qPCR in South-Eastern Tanzania.坦桑尼亚东南部使用快速诊断检测、显微镜检查和定量聚合酶链反应收集的人群调查数据得出的精细疟疾分层比较。
Malar J. 2024 Dec 18;23(1):376. doi: 10.1186/s12936-024-05191-8.
5
Designing malaria surveillance strategies for mobile and migrant populations in Nepal: a mixed-methods study.设计尼泊尔流动和移民人群疟疾监测策略:一项混合方法研究。
Malar J. 2019 May 3;18(1):158. doi: 10.1186/s12936-019-2791-1.
6
Spatio-temporal distribution of malaria and its association with climatic factors and vector-control interventions in two high-risk districts of Nepal.尼泊尔两个高风险地区疟疾的时空分布及其与气候因素和病媒控制干预措施的关联。
Malar J. 2014 Nov 25;13:457. doi: 10.1186/1475-2875-13-457.
7
Elimination of visceral leishmaniasis in Nepal: pipe-dreams and possibilities.尼泊尔消除内脏利什曼病:空想与可能性
Kathmandu Univ Med J (KUMJ). 2006 Oct-Dec;4(4):488-96.
8
Village-integrated eye workers for prevention of corneal ulcers in Nepal (VIEW study): a cluster-randomised controlled trial.尼泊尔村落一体化眼保健工作者预防角膜溃疡研究(VIEW 研究):一项群组随机对照试验
Lancet Glob Health. 2022 Apr;10(4):e501-e509. doi: 10.1016/S2214-109X(21)00596-9.
9
The effects and contribution of childhood diseases on the geographical distribution of all-cause under-five mortality in Uganda.儿童疾病对乌干达五岁以下儿童全死因死亡率地理分布的影响及作用。
Parasite Epidemiol Control. 2019 Jan 31;5:e00089. doi: 10.1016/j.parepi.2019.e00089. eCollection 2019 May.
10
Malaria risk stratification in Lao PDR guides program planning in an elimination setting.老挝人民民主共和国的疟疾风险分层指导消除规划。
Sci Rep. 2024 Jan 19;14(1):1709. doi: 10.1038/s41598-024-52115-2.

引用本文的文献

1
Malaria elimination challenges in countries approaching the last mile: a discussion among regional stakeholders.接近疟疾消除最后阶段国家面临的挑战:地区利益相关者之间的讨论
Malar J. 2024 Dec 26;23(1):401. doi: 10.1186/s12936-024-05215-3.
2
Comparison of fine-scale malaria strata derived from population survey data collected using RDTs, microscopy and qPCR in South-Eastern Tanzania.坦桑尼亚东南部使用快速诊断检测、显微镜检查和定量聚合酶链反应收集的人群调查数据得出的精细疟疾分层比较。
Malar J. 2024 Dec 18;23(1):376. doi: 10.1186/s12936-024-05191-8.
3
Analyzing Spatial and Temporal Patterns of Designated Malaria Risk Areas in Nepal from 2018 to 2021.

本文引用的文献

1
Patients' adherence to artemisinin-based combination therapy and healthcare workers' perception and practice in Savannakhet province, Lao PDR.老挝人民民主共和国沙湾拿吉省患者对基于青蒿素的联合疗法的依从性以及医护人员的认知与实践
Trop Med Health. 2018 Dec 22;46:44. doi: 10.1186/s41182-018-0125-6. eCollection 2018.
2
Efficacy of artemether-lumefantrine for the treatment of uncomplicated malaria in Nepal.蒿甲醚-本芴醇治疗尼泊尔非复杂性疟疾的疗效
Trop Dis Travel Med Vaccines. 2018 Aug 14;4:9. doi: 10.1186/s40794-018-0068-2. eCollection 2018.
3
Epidemiology of Malaria Infection in Nepal.
分析 2018 年至 2021 年尼泊尔指定疟疾风险地区的时空分布模式。
Vector Borne Zoonotic Dis. 2023 Jun;23(6):350-353. doi: 10.1089/vbz.2022.0097. Epub 2023 Apr 4.
4
Factors affecting anaemia among women of reproductive age in Nepal: a multilevel and spatial analysis.尼泊尔育龄妇女贫血的影响因素:多水平和空间分析。
BMJ Open. 2021 Mar 29;11(3):e041982. doi: 10.1136/bmjopen-2020-041982.
5
Malaria epidemiology and stratification of incidence in the malaria elimination setting in Harari Region, Eastern Ethiopia.在埃塞俄比亚东部哈拉里地区消除疟疾背景下的疟疾流行病学和发病率分层。
Infect Dis Poverty. 2020 Nov 22;9(1):160. doi: 10.1186/s40249-020-00773-5.
6
G6PD deficiency in malaria endemic areas of Nepal.尼泊尔疟疾流行地区的葡萄糖-6-磷酸脱氢酶缺乏症。
Malar J. 2020 Aug 12;19(1):287. doi: 10.1186/s12936-020-03359-6.
7
The durability of long-lasting insecticidal nets distributed to the households between 2009 and 2013 in Nepal.2009年至2013年间在尼泊尔分发给各家庭的长效驱虫蚊帐的耐用性。
Trop Med Health. 2020 May 19;48:36. doi: 10.1186/s41182-020-00223-w. eCollection 2020.
8
Spatio-temporal dynamics of Plasmodium falciparum transmission within a spatial unit on the Colombian Pacific Coast.哥伦比亚太平洋海岸某空间单位内疟原虫传播的时空动态。
Sci Rep. 2020 Feb 28;10(1):3756. doi: 10.1038/s41598-020-60676-1.
尼泊尔疟疾感染的流行病学。
Am J Trop Med Hyg. 2018 Sep;99(3):680-687. doi: 10.4269/ajtmh.18-0373. Epub 2018 Jul 12.
4
Mapping the stability of malaria hotspots in Bangladesh from 2013 to 2016.绘制孟加拉国 2013 年至 2016 年疟疾热点地区的稳定性图谱。
Malar J. 2018 Jul 11;17(1):259. doi: 10.1186/s12936-018-2405-3.
5
Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.老挝和柬埔寨的荧光斑点试验和快速诊断检测法比较葡萄糖-6-磷酸脱氢酶状态。
Malar J. 2018 Jun 22;17(1):243. doi: 10.1186/s12936-018-2390-6.
6
The feasibility and acceptability of mass drug administration for malaria in Cambodia: a mixed-methods study.柬埔寨大规模疟疾药物治疗的可行性与可接受性:一项混合方法研究
Trans R Soc Trop Med Hyg. 2018 Jun 1;112(6):264-271. doi: 10.1093/trstmh/try053.
7
Malaria Elimination: Time to Target All Species.消除疟疾:全面瞄准所有疟原虫。
Am J Trop Med Hyg. 2018 Jul;99(1):17-23. doi: 10.4269/ajtmh.17-0869. Epub 2018 May 10.
8
Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme.缅甸东部普遍获得早期诊断和治疗以及有针对性的大规模药物治疗对恶性疟原虫疟疾的影响:区域消除规划的观察性研究。
Lancet. 2018 May 12;391(10133):1916-1926. doi: 10.1016/S0140-6736(18)30792-X. Epub 2018 Apr 24.
9
A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multidrug-Resistant Falciparum Malaria in Cambodian Villages.大规模药物给药控制试验以阻断柬埔寨村庄耐多药恶性疟原虫的传播。
Clin Infect Dis. 2018 Aug 31;67(6):817-826. doi: 10.1093/cid/ciy196.
10
Why do people participate in mass anti-malarial administration? Findings from a qualitative study in Nong District, Savannakhet Province, Lao PDR (Laos).为什么人们会参与大规模的抗疟管理?来自老挝沙拉湾省农区的定性研究结果。
Malar J. 2018 Jan 9;17(1):15. doi: 10.1186/s12936-017-2158-4.